PRMT5 promotes chemotherapy‐induced neuroendocrine differentiation in NSCLC

BACKGROUND: In response to therapeutic treatments, cancer cells can exhibit a variety of resistance phenotypes including neuroendocrine differentiation (NED). NED is a process by which cancer cells can transdifferentiate into neuroendocrine‐like cells in response to treatments, and is now widely acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Qi, Liu, Yi, Deng, Xuehong, Hu, Chang‐Deng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290919/
https://www.ncbi.nlm.nih.gov/pubmed/37140020
http://dx.doi.org/10.1111/1759-7714.14921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290919/
https://www.ncbi.nlm.nih.gov/pubmed/37140020
http://dx.doi.org/10.1111/1759-7714.14921

Ejemplares similares